623 related articles for article (PubMed ID: 18070024)
1. Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients.
Dalamaga M; Karmaniolas K; Matekovits A; Migdalis I; Papadavid E
J Eur Acad Dermatol Venereol; 2008 May; 22(5):543-8. PubMed ID: 18070024
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and prognostic value of cutaneous manifestations in patients with myelodysplastic syndrome.
Farah C; Bulai Livideanu C; Jegu J; Paul C; Viraben R; Lamant L; Delavigne K; Adoue D; Laurent G; Beyne Rauzy O
J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1171-5. PubMed ID: 20202054
[TBL] [Abstract][Full Text] [Related]
3. Langerhans cell histiocytosis associated with myelodysplastic syndrome in adults.
Billings SD; Hans CP; Schapiro BL; Martin RW; Fivenson D; Fruland JE; Moores WB; Cotton J
J Cutan Pathol; 2006 Feb; 33(2):171-4. PubMed ID: 16420314
[TBL] [Abstract][Full Text] [Related]
4. Wegener's granulomatosis. Dermatological manifestations in 75 cases with clinicopathologic correlation.
Francès C; Du LT; Piette JC; Saada V; Boisnic S; Wechsler B; Blétry O; Godeau P
Arch Dermatol; 1994 Jul; 130(7):861-7. PubMed ID: 8024273
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study.
Giannouli S; Voulgarelis M; Zintzaras E; Tzioufas AG; Moutsopoulos HM
Rheumatology (Oxford); 2004 May; 43(5):626-32. PubMed ID: 14983106
[TBL] [Abstract][Full Text] [Related]
6. [Immunologic phenomena as the first sign of myelodysplastic syndrome].
van Rijn RS; Wittebol S; Graafland AD; Kramer MH
Ned Tijdschr Geneeskd; 2001 Aug; 145(32):1529-33. PubMed ID: 11525083
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
[TBL] [Abstract][Full Text] [Related]
8. [Systemic and autoimmune manifestations in myelodysplastic syndromes].
Fain O; Braun T; Stirnemann J; Fenaux P
Rev Med Interne; 2011 Sep; 32(9):552-9. PubMed ID: 20850913
[TBL] [Abstract][Full Text] [Related]
9. [Appearance of Sweet's syndrome in a patient with myelodysplastic syndrome (MDS) without relation to the hematological findings of MDS].
Hasegawa Y; Tomiyama J; Ninomiya H; Abe T
Rinsho Ketsueki; 1989 Jun; 30(6):863-7. PubMed ID: 2795896
[TBL] [Abstract][Full Text] [Related]
10. [Immunologic manifestations in myelodysplastic syndrome].
Loraas A; Lamvik J; Matre J
Tidsskr Nor Laegeforen; 1994 May; 114(14):1609-11. PubMed ID: 8079262
[TBL] [Abstract][Full Text] [Related]
11. [Skin manifestations associated with myelodysplastic syndromes].
Morand JJ; Lightburn E; Richard MA; Hesse-Bonerandi S; Carsuzaa F; Grob JJ
Rev Med Interne; 2001 Sep; 22(9):845-53. PubMed ID: 11599186
[TBL] [Abstract][Full Text] [Related]
12. [Myelodysplastic syndrome with Sweet's syndrome--one case report and literature review].
Zhang F; Lin Y; Li J
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):369-70. PubMed ID: 11721436
[TBL] [Abstract][Full Text] [Related]
13. Vasculitides associated with malignancies: analysis of sixty patients.
Fain O; Hamidou M; Cacoub P; Godeau B; Wechsler B; Pariès J; Stirnemann J; Morin AS; Gatfosse M; Hanslik T; Belmatoug N; Blétry O; Cevallos R; Delevaux I; Fisher E; Hayem G; Kaplan G; Le Hello C; Mouthon L; Larroche C; Lemaire V; Piette AM; Piette JC; Ponge T; Puechal X; Rossert J; Sarrot-Reynauld F; Sicard D; Ziza JM; Kahn MF; Guillevin L
Arthritis Rheum; 2007 Dec; 57(8):1473-80. PubMed ID: 18050165
[TBL] [Abstract][Full Text] [Related]
14. Karyotypic analysis of bone marrow cells in pyodermic lesions associated with myelodysplastic syndrome.
Hamada T; Matsuura H; Oono T; Morizane S; Yamasaki O; Asagoe K; Yamamoto T; Tsuji K; Iwatsuki K
Arch Dermatol; 2008 May; 144(5):643-8. PubMed ID: 18490591
[TBL] [Abstract][Full Text] [Related]
15. [Mixed myelodysplastic and myeloproliferative syndromes].
Neuwirtová R; Mociková K; Jelínek J; Musilová J; Havlícek F; Adamkov M; Michalová K; Cermák J; Jonásová A; Smolíková A; Straub J; Tothová E; Voglová J; Vozobulová V; Waltrová L
Cas Lek Cesk; 1997 Dec; 136(23):724-9. PubMed ID: 9476375
[TBL] [Abstract][Full Text] [Related]
16. [The myelodysplastic syndrome and autoimmunity].
Laursen SB; Nielsen MØ; Hasselbalch HC
Ugeskr Laeger; 2009 Sep; 171(37):2639-42. PubMed ID: 19758507
[TBL] [Abstract][Full Text] [Related]
17. Low C3 levels is associated with neutropenia in a proportion of patients with myelodysplastic syndrome: retrospective analysis.
Kim KJ; Kwok SK; Park YJ; Kim WU; Cho CS
Int J Rheum Dis; 2012 Feb; 15(1):86-94. PubMed ID: 22324951
[TBL] [Abstract][Full Text] [Related]
18. Clinical and histopathologic features of 8 patients with microscopic polyangiitis including two with a slowly progressive clinical course.
Kawakami T; Kawanabe T; Saito C; Kannari M; Mizoguchi M; Nagafuchi H; Okazaki T; Ozaki S; Kimura K; Soma Y
J Am Acad Dermatol; 2007 Nov; 57(5):840-8. PubMed ID: 17939936
[TBL] [Abstract][Full Text] [Related]
19. The relationship between myelodysplastic syndromes and autoimmune disorders.
Zhao S; Mao H; Wang H; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):311-3. PubMed ID: 12411063
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the prognostic significance of eosinophilia and basophilia in a larger cohort of patients with myelodysplastic syndromes.
Wimazal F; Germing U; Kundi M; Noesslinger T; Blum S; Geissler P; Baumgartner C; Pfeilstoecker M; Valent P; Sperr WR
Cancer; 2010 May; 116(10):2372-81. PubMed ID: 20209617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
